A detailed history of New World Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, New World Advisors LLC holds 700 shares of AMGN stock, worth $202,929. This represents 0.06% of its overall portfolio holdings.

Number of Shares
700
Previous 700 -0.0%
Holding current value
$202,929
Previous $218,000 3.21%
% of portfolio
0.06%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$262.75 - $319.31 $183,925 - $223,517
700 New
700 $218,000
Q4 2023

Jan 29, 2024

BUY
$255.7 - $288.46 $178,990 - $201,922
700 New
700 $201,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $176,862 - $206,104
-797 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $172,454 - $205,362
797 New
797 $203,000
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $119,523 - $140,108
-717 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $129,683 - $146,181
717 New
717 $136,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track New World Advisors LLC Portfolio

Follow New World Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New World Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on New World Advisors LLC with notifications on news.